LUM002

Shire Acquisition Bolsters Its Rare, And Maybe Not-So-Rare, Disease Portfolio
Seeking Alpha
Mon, 05/19/14 - 09:23 am
Shire
M&A
liver disease
Lumena Pharmaceuticals
LUM001
LUM002
obesity